Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Endometrial Neoplasms

cetylpyridinium chloride anhydrous has been researched along with Endometrial Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Brosens, JJ; Brunner, SF; Butler, T; Campbell, PJ; Coorens, THH; Dawson, KJ; Dentro, SC; Ellis, P; Hooks, Y; Iacobuzio-Donahue, CA; Jimenez-Linan, M; Lee-Six, H; Leongamornlert, D; Mahbubani, KT; Martincorena, I; Maura, F; Mitchell, TJ; Moody, S; Moore, L; Nangalia, J; Rahbari, R; Saeb-Parsy, K; Sanders, MA; Stratton, MR; Tarpey, PS1
Mariani, A; Walther-Antonio, MRS1
Warren, JV1
Wen, W1
Chen, X; Jin, Y; Li, H; Liu, X; Mao, J; Su, Z; Wang, Z; Wu, X; Zhang, J; Zhu, H1
Blumenfeld, Z1
Raloff, J1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Endometrial Neoplasms

ArticleYear
Hormonal suppressive therapy for endometriosis may not improve patient health.
    Fertility and sterility, 2004, Volume: 81, Issue:3

    Topics: Danazol; Endometrial Neoplasms; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Health; Humans; Loss of Heterozygosity; Patients; Progestins

2004

Other Studies

6 other study(ies) available for cetylpyridinium chloride anhydrous and Endometrial Neoplasms

ArticleYear
The mutational landscape of normal human endometrial epithelium.
    Nature, 2020, Volume: 580, Issue:7805

    Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Aging; Carcinogenesis; Clone Cells; DNA Mutational Analysis; Endometrial Neoplasms; Endometrium; Epithelial Cells; Epithelium; Female; Health; Humans; Middle Aged; Mutation; Parity; Time Factors; Young Adult

2020
Are early screening biomarkers for endometrial cancer needed to reduce health disparities?
    American journal of obstetrics and gynecology, 2019, Volume: 220, Issue:4

    Topics: Biomarkers; Early Detection of Cancer; Endometrial Neoplasms; Female; Health; Hemorrhage; Humans; Mass Screening; Role

2019
Third world has much to teach us, says Frederick Zuspan after stint in Zaire.
    Ob/gyn World, 1984, Volume: 1, Issue:3

    Topics: Africa; Africa South of the Sahara; Africa, Northern; Breast Neoplasms; Delivery of Health Care; Democratic Republic of the Congo; Developing Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Health; Health Services; Health Services, Indigenous; Maternal Welfare; Maternal-Child Health Centers; Medicine; Pelvic Inflammatory Disease; Primary Health Care; Program Development; Puerperal Disorders; Rural Health Services; Sexually Transmitted Diseases; Tetanus; Uterine Cervical Neoplasms

1984
China: a new medicine born of tradition.
    The Unesco courier, 1979, Volume: 7

    Topics: Asia; Asia, Eastern; China; Community Health Workers; Contraception; Delivery of Health Care; Developing Countries; Disease; Endometrial Neoplasms; Family Planning Services; Health; Health Personnel; Health Services; Heart Diseases; Hypertension; Medicine; Neoplasms; Plants, Medicinal; Pregnancy; Pregnancy Complications; Pregnancy, Ectopic; Vascular Diseases

1979
The safety of Sino-implant -- 3-year clinical observation.
    Reproduction and contraception, 1999, Volume: 10, Issue:4

    Topics: Asia; Asia, Eastern; Biology; Blood; Blood Pressure; Body Weight; China; Contraception; Developing Countries; Disease; Endometrial Neoplasms; Family Planning Services; Genitalia; Genitalia, Female; Health; Neoplasms; Ovarian Cysts; Physiology; Public Health; Research; Safety; Urogenital System; Uterus

1999
Tamoxifen turmoil: new issues emerge as healthy women volunteer to take a potent drug.
    Science news, 1994, Oct-31, Volume: 146, Issue:17

    Topics: Academies and Institutes; Breast Neoplasms; Canada; Consent Forms; Disclosure; Drug-Related Side Effects and Adverse Reactions; Endometrial Neoplasms; Female; Health; Hormones; Human Experimentation; Humans; Informed Consent; Mortality; Multicenter Studies as Topic; Pharmaceutical Preparations; Physicians; Placebos; Preventive Medicine; Research Personnel; Research Subjects; Risk; Risk Assessment; Tamoxifen; United States; Volunteers; Women

1994